Selzentry News
Most Popular Selzentry Story
Selzentry - 2007 FDA approvals
Drug: Selzentry (maraviroc) Indication: HIV Company: Pfizer Approval Date: August 6, 2007 Scoop: Selzentry is a CCR5 antagonist, which prevents the virus from entering white blood cells. The process Read more...
Latest Headlines
- January 30, 2008
- January 9, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
